192 related articles for article (PubMed ID: 25943792)
21. Toxicity testing: creating a revolution based on new technologies.
Bhogal N; Grindon C; Combes R; Balls M
Trends Biotechnol; 2005 Jun; 23(6):299-307. PubMed ID: 15922082
[TBL] [Abstract][Full Text] [Related]
22. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
23. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
[TBL] [Abstract][Full Text] [Related]
24. Toxicity testing in the 21st century: how will it affect risk assessment?
Rhomberg LR
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
[TBL] [Abstract][Full Text] [Related]
25. The future trajectory of adverse outcome pathways: a commentary.
Sewell F; Gellatly N; Beaumont M; Burden N; Currie R; de Haan L; Hutchinson TH; Jacobs M; Mahony C; Malcomber I; Mehta J; Whale G; Kimber I
Arch Toxicol; 2018 Apr; 92(4):1657-1661. PubMed ID: 29549413
[TBL] [Abstract][Full Text] [Related]
26. Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.
Sewell F; Doe J; Gellatly N; Ragan I; Burden N
Regul Toxicol Pharmacol; 2017 Oct; 89():50-56. PubMed ID: 28689746
[TBL] [Abstract][Full Text] [Related]
27. Alternatives to animal testing: current status and future perspectives.
Liebsch M; Grune B; Seiler A; Butzke D; Oelgeschläger M; Pirow R; Adler S; Riebeling C; Luch A
Arch Toxicol; 2011 Aug; 85(8):841-58. PubMed ID: 21607681
[TBL] [Abstract][Full Text] [Related]
28. Working in partnership to advance the 3Rs in toxicity testing.
Holmes AM; Creton S; Chapman K
Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
[TBL] [Abstract][Full Text] [Related]
29. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
30. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
Richmond J
ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
[TBL] [Abstract][Full Text] [Related]
31. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
32. A high-level overview of the OECD AOP Development Programme.
Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
[TBL] [Abstract][Full Text] [Related]
33. Animal testing: more than a cosmetic change.
Abbott A
Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
[No Abstract] [Full Text] [Related]
34. Possibilities for a new approach to chemicals risk assessment -- the report of a FRAME workshop.
Combes R; Balls M; Illing P; Bhogal N; Dale J; Duvé G; Feron V; Grindon C; Gülden M; Loizou G; Priston R; Westmoreland C;
Altern Lab Anim; 2006 Dec; 34(6):621-49. PubMed ID: 17266394
[No Abstract] [Full Text] [Related]
35. Consensus report on the future of animal-free systemic toxicity testing.
Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
[TBL] [Abstract][Full Text] [Related]
36. Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.
Judson R; Kavlock R; Martin M; Reif D; Houck K; Knudsen T; Richard A; Tice RR; Whelan M; Xia M; Huang R; Austin C; Daston G; Hartung T; Fowle JR; Wooge W; Tong W; Dix D
ALTEX; 2013; 30(1):51-6. PubMed ID: 23338806
[TBL] [Abstract][Full Text] [Related]
37. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
Mangipudy R; Burkhardt J; Kadambi VJ
Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
[TBL] [Abstract][Full Text] [Related]
38. Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations.
Bajard L; Adamovsky O; Audouze K; Baken K; Barouki R; Beltman JB; Beronius A; Bonefeld-Jørgensen EC; Cano-Sancho G; de Baat ML; Di Tillio F; Fernández MF; FitzGerald RE; Gundacker C; Hernández AF; Hilscherova K; Karakitsios S; Kuchovska E; Long M; Luijten M; Majid S; Marx-Stoelting P; Mustieles V; Negi CK; Sarigiannis D; Scholz S; Sovadinova I; Stierum R; Tanabe S; Tollefsen KE; van den Brand AD; Vogs C; Wielsøe M; Wittwehr C; Blaha L
Environ Res; 2023 Jan; 217():114650. PubMed ID: 36309218
[TBL] [Abstract][Full Text] [Related]
39. Advancing the adverse outcome pathway framework-An international horizon scanning approach.
LaLone CA; Ankley GT; Belanger SE; Embry MR; Hodges G; Knapen D; Munn S; Perkins EJ; Rudd MA; Villeneuve DL; Whelan M; Willett C; Zhang X; Hecker M
Environ Toxicol Chem; 2017 Jun; 36(6):1411-1421. PubMed ID: 28543973
[TBL] [Abstract][Full Text] [Related]
40. Testing and assessment strategies, including alternative and new approaches.
Meyer O
Toxicol Lett; 2003 Apr; 140-141():21-30. PubMed ID: 12676447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
